Commentaries



Volume 127

Integrin-linked kinase: a new member of the kinases involved in hypertensive end-organ damage?
T. Obama and S. Eguchi..........15‑17
Published as Immediate Publication 31 January 2014, doi:10.1042/CS20140081
Abstract | Full text HTML | Full text PDF | Accompanying paper

Volume 126

Is it tea time for portal hypertension?
J. Gracia‑Sancho and J. Bosch..........631‑632
Published as Immediate Publication 20 December 2013, doi:10.1042/CS20130810
Abstract | Full text HTML | Full text PDF | Accompanying paper

Volume 124

A tailored approach to asthma management: Arg16 holds the key?
I. Sayers..........517‑519
Published as Immediate Publication 3 December 2012, doi:10.1042/CS20120640
Abstract | Full text HTML | Full text PDF | Accompanying paper
The promise and challenge of systems biology in translational medicine
V. Thongboonkerd..........389‑390
Published as Immediate Publication 22 October 2012, doi:10.1042/CS20120565
Abstract | Full text HTML | Full text PDF | Accompanying paper
Does uric acid qualify as an independent risk factor for cardiovascular mortality?
P. Jeemon and D. Prabhakaran..........255‑257
Published as Immediate Publication 9 October 2012, doi:10.1042/CS20120524
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 123

The long and winding TRAIL to weight loss
R. M. E. Blümer and G. R. Steinberg..........545‑546
Published as Immediate Publication 28 June 2012, doi:10.1042/CS20120356
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 121

Remote hindlimb preconditioning and hepatoprotection: NO-table strides against liver ischaemia/reperfusion injury
N. C. Teoh..........253‑255
Published as Immediate Publication 10 May 2011, doi:10.1042/CS20110243
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 120

Hunting for fibrosis progression genes in hepatitis C patients
P. Invernizzi..........285‑286
Published as Immediate Publication 18 November 2010, doi:10.1042/CS20100553
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Arachidonic acid fights palmitate: new insights into fatty acid toxicity in β-cells
H. Ortsäter..........179‑181
Published as Immediate Publication 2 November 2010, doi:10.1042/CS20100521
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 119

Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis
K. L. Becker..........515‑517
Published as Immediate Publication 22 July 2010, doi:10.1042/CS20100367
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Protein catabolism and impairment of skeletal muscle insulin signalling in heart failure
P. C. Schulze..........465‑466
Published as Immediate Publication 15 July 2010, doi:10.1042/CS20100363
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Will high-sensitive troponin immunoassays lead to more clarity or confusion in clinical practice?
A. Clerico and A. Giannoni..........203‑205
Published as Immediate Publication 4 May 2010, doi:10.1042/CS20100234
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 118

Clopidogrel application: beyond coronary artery disease
C. Zeng..........459‑461
Published as Immediate Publication 4 November 2009, doi:10.1042/CS20090546
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Hypoxia and non-alcoholic fatty liver disease
C. D. Byrne..........397‑400
Published as Immediate Publication 10 November 2009, doi:10.1042/CS20090565
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Chronic fatigue syndrome: comments on deconditioning, blood volume and resulting cardiac function
J. M. Stewart..........121‑123
Published as Immediate Publication 18 June 2009, doi:10.1042/CS20090327
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Central sympathetic outflow to skeletal muscle: the major link between non-esterified fatty acids and elevated blood pressure?
M. Schlaich..........43‑45
Published as Immediate Publication 13 July 2009, doi:10.1042/CS20090369
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 117

New statistical methods for the evaluation of cardiovascular risk markers: what the clinician should know
H. Røsjø and T. Omland (see accompanying paper pp. 31‑39)...................13‑15
Published as Immediate Publication 7 April 2009, doi:10.1042/CS20090185
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 116

Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease
T. J. Corte and S. J. Wort (see accompanying paper pp. 497–505).........493–495
Published as Immediate Publication 27 November 2008, doi:10.1042/CS20080590
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Magic angle spinning magnetic resonance: a novel method opening up translational research into NAFLD?
C. Boesch (see accompanying paper pp. 403–413).........401–402
Published as Immediate Publication 4 December 2008, doi:10.1042/CS20080621
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Interval exercise is a path to good health, but how much, how often and for whom?
M. J. MacDonald and K. D. Currie (see accompanying paper pp. 317–326).........315–316
Published as Immediate Publication 10 December 2008, doi:10.1042/CS20080632
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Angiogenic factors and pre-eclampsia: an early marker is needed
H. Stepan (see accompanying paper pp. 265–272).........231–232
Published as Immediate Publication 25 November 2008, doi:10.1042/CS20080598
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
More knocks to the oxidation hypothesis for vascular disease?
A. Mullan and N. Sattar (see accompanying paper pp. 53–60).........41–43
Published as Immediate Publication 10 October 2008, doi:10.1042/CS20080486
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Statins for heart failure: still caught in no man's land?
S. von Haehling (see accompanying paper pp. 45–52).........37–39
Published as Immediate Publication 29 October 2008, doi:10.1042/CS20080530
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 115

Immune regulatory cells: circulating biomarker factories in cardiovascular disease
G. Pasterkamp, D. Versteeg and D. P. V. DE Kleijn (see accompanying paper pp. 133–140).........129–131
Published as Immediate Publication 3 April 2008, doi:10.1042/CS20080089
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 114

Glucagon and hyperglycaemia in diabetes
P. E. Cryer (see accompanying paper pp. 591–601).........589–590
Published as Immediate Publication 15 January 2008, doi:10.1042/CS20070434
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease
S. K. Gan and G. F. Watts (see accompanying paper, pp. 547–552).........543–545
Published as Immediate Publication 8 January 2008, doi:10.1042/CS20070461
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Erythropoietin in cardiovascular diseases: exploring new avenues
P. van der Meer, D. J. van Veldhuisen and J. L. Januzzi (see accompanying paper pp. 293–304).........289–291
Published as Immediate Publication 14 November 2007, doi:10.1042/CS20070392
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Does compensatory nitric oxide and angiotensin II receptor activity reduce arterial stiffness in early-stage insulin resistance?
R. J. Woodman (see accompanying paper pp. 139–147).........119–121
Published as Immediate Publication 19 September 2007, doi:10.1042/CS20070321
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 113

High-fat diets: healthy or unhealthy?
M. C. Guldstrand and C. L. Simberg (see accompanying paper pp. 417–425).........397–399
Published as Immediate Publication 23 August 2007, doi:10.1042/CS20070263
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?
A. Sniderman, S. D. Bailey and J. C. Engert (see accompanying paper pp. 375–381).........365–367
Published as Immediate Publication 4 July 2007, doi:10.1042/CS20070220
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper
Normative values, reliability and sample size estimates in heart rate variability
G. Sandercock (see accompanying paper pp. 131–140).........129–130
Published as Immediate Publication 23 April 2007, doi:10.1042/CS20070137
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF
C-reactive protein: a marker or a player?
T. Nyström (see accompanying paper pp. 103–108).........79–81
Published as Immediate Publication 23 April 2007, doi:10.1042/CS20070121
Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Volume 111

Testosterone and vascular reactivity
R. Iliescu and J. F. Reckelhoff .........251–252
b-Adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
C. J. Mathias .........189–191
Are the lipid-modifying effects of fibrates mediated by alterations in plasma lipid transfer activity?
G. F. Lewis .........185–187

Volume 110

Local inflammation, endothelial dysfunction and fibrinolysis in coronary heart disease
G. D. O. Lowe .........327–328
How does endothelin induce vascular oxidative stress in mineralocorticoid hypertension?
D. M. Pollock .........205–206
What role do adrenoreceptor polymorphisms play in modifying cardiovascular responses in obstructive sleep apnoea?
N. McArdle .........89–91


Volume 109

Coronary flow responses to exercise training: further evidence of the benefit of an underutilized therapeutic modality
T. H. Marwick .........265–266
Can we diagnose, treat or even understand neurally mediated syncope?
S. R. Raj, A. Diedrich and I. Biaggioni.........161–163


Volume 108

C-reactive protein and statins: IL-8 as a molecular link?
P. E. Szmitko and S. Verma .........493–495
New evidence of baroreflex dysfunction in congenital central hypoventilation syndrome
P. van de Borne .........215–216


Volume 107

Running for health: how much running for how much health?
K. McCully .........559–560
Resolving inconsistency in the results of genetic association studies of cardiovascular disease
A. Hingorani .........251–253
Renin–angiotensin vaccine: old story, new project ‘efficacy versus safety’
J.-B. Michel .........145–147
Stroke and blood pressure variability
J. C. T. Pepperell .........27–28


Volume 106

Sympathetic overactivity in ischaemic heart disease
A. Malliani and N. Montano .........567–568
Inspiratory flow limitation in obstructive sleep apnoea patients
R. Farré .........563–565
Diet, the endothelium and atherosclerosis
A. D. Hingorani .........447–448
Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease?
N. Sattar .........443–445
Can mild-to-moderate hyperhomocysteinaemia impair endothelial function in the absence of other risk factors for cardiovascular disease?
M. L. H. Honing and C. D. A. Stehouwer ..........345–346
Aging, physical fitness and endothelial function: are all ultracentenarians marathon runners?
G. Grassi.........239–240
Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?
I. A. Leclercq.........235–237
Protein, programming and plumpness: is there a link?
R. R. Huxley.........113–114
A feeling in the waters: diagnosis of heart failure using urinary natriuretic peptides
H. Krum and D. Liew.........111–112
Genetic risk markers for post-angioplasty restenosis: what should we expect?
F. R. Green.........1–2